Defining drugs: how government became the arbiter of pharmaceutical fact
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New Brunswick, N.J.
Transaction Publishers
2003
|
Schlagworte: | |
Online-Zugang: | Table of contents Inhaltsverzeichnis |
Beschreibung: | Includes bibliographical references (p. 139-155) and index |
Beschreibung: | xxviii, 163 p. ill. : 24 cm |
ISBN: | 0765801892 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV014842400 | ||
003 | DE-604 | ||
005 | 20030625 | ||
007 | t | ||
008 | 021029s2003 xxua||| |||| 00||| eng d | ||
010 | |a 2002075086 | ||
020 | |a 0765801892 |9 0-7658-0189-2 | ||
035 | |a (OCoLC)50866855 | ||
035 | |a (DE-599)BVBBV014842400 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-12 | ||
050 | 0 | |a RA401.A3 | |
082 | 0 | |a 353.9/98/0973 |2 21 | |
100 | 1 | |a Parrish, Richard Henry |e Verfasser |0 (DE-588)12499475X |4 aut | |
245 | 1 | 0 | |a Defining drugs |b how government became the arbiter of pharmaceutical fact |c Richard Henry Parrish II |
264 | 1 | |a New Brunswick, N.J. |b Transaction Publishers |c 2003 | |
300 | |a xxviii, 163 p. |b ill. : 24 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references (p. 139-155) and index | ||
650 | 4 | |a Drug Industry |x standards |z United States | |
650 | 4 | |a Government Regulation |x history |z United States | |
650 | 4 | |a Health Policy |x history |z United States | |
650 | 4 | |a Legislation, Drug |x history |z United States | |
650 | 4 | |a Pharmaceutical Preparations |x standards |z United States | |
650 | 4 | |a Pharmaceutical policy |z United States | |
650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Regulierung |0 (DE-588)4201190-5 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
689 | 0 | 2 | |a Regulierung |0 (DE-588)4201190-5 |D s |
689 | 0 | |5 DE-604 | |
856 | 4 | |u http://www.loc.gov/catdir/toc/fy036/2002075086.html |3 Table of contents | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010040905&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-010040905 |
Datensatz im Suchindex
_version_ | 1804129609995780096 |
---|---|
adam_text | RICHARD HENRY PARRISH II HOW GOVERNMENT BECAME THE ARMTER OF
PHARMACEUTICAL FACT TRANSACTION PUBLISHERS NEW BRUNSWICK (U.S.A.) AND
LONDON (ILK.) CONTENTS FIGURES IX FOREWORD XI PREFACE XV
ACKNOWLEDGEMENTS XVII INTRODUCTION XXI 1. THE SEARCH FOR ORDER BETWEEN
PROGRESSIVISM AND THE NEW DEAL 1 2. PHARMACEUTICAL FACT 29 3. LETTERS
BETWEEN LEADERS 47 4. DISPENSING DOCTORS AND COUNTER-PRESCRIBING
PHARMACISTS 67 5. NEGOTIATING REALITY: THE CONSTRUCTION OF ENFORCEABLE
89 PHARMACEUTICAL STANDARDS DENOUEMENT: DEFINING DRUGS: CONSEQUENCES OF
SEEKING 115 EXTERNAL GOVERNANCE METHODOLOGY AND BIBLIOGRAPHIC SOURCES
135 BIBLIOGRAPHY 139 INDEX 157
|
any_adam_object | 1 |
author | Parrish, Richard Henry |
author_GND | (DE-588)12499475X |
author_facet | Parrish, Richard Henry |
author_role | aut |
author_sort | Parrish, Richard Henry |
author_variant | r h p rh rhp |
building | Verbundindex |
bvnumber | BV014842400 |
callnumber-first | R - Medicine |
callnumber-label | RA401 |
callnumber-raw | RA401.A3 |
callnumber-search | RA401.A3 |
callnumber-sort | RA 3401 A3 |
callnumber-subject | RA - Public Medicine |
ctrlnum | (OCoLC)50866855 (DE-599)BVBBV014842400 |
dewey-full | 353.9/98/0973 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 353 - Specific fields of public administration |
dewey-raw | 353.9/98/0973 |
dewey-search | 353.9/98/0973 |
dewey-sort | 3353.9 298 3973 |
dewey-tens | 350 - Public administration and military science |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02043nam a2200505zc 4500</leader><controlfield tag="001">BV014842400</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030625 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">021029s2003 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002075086</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0765801892</subfield><subfield code="9">0-7658-0189-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50866855</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014842400</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA401.A3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">353.9/98/0973</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Parrish, Richard Henry</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)12499475X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Defining drugs</subfield><subfield code="b">how government became the arbiter of pharmaceutical fact</subfield><subfield code="c">Richard Henry Parrish II</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New Brunswick, N.J.</subfield><subfield code="b">Transaction Publishers</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxviii, 163 p.</subfield><subfield code="b">ill. : 24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 139-155) and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Government Regulation</subfield><subfield code="x">history</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Policy</subfield><subfield code="x">history</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="x">history</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/fy036/2002075086.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010040905&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010040905</subfield></datafield></record></collection> |
geographic | USA USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV014842400 |
illustrated | Illustrated |
indexdate | 2024-07-09T19:07:52Z |
institution | BVB |
isbn | 0765801892 |
language | English |
lccn | 2002075086 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010040905 |
oclc_num | 50866855 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | xxviii, 163 p. ill. : 24 cm |
publishDate | 2003 |
publishDateSearch | 2003 |
publishDateSort | 2003 |
publisher | Transaction Publishers |
record_format | marc |
spelling | Parrish, Richard Henry Verfasser (DE-588)12499475X aut Defining drugs how government became the arbiter of pharmaceutical fact Richard Henry Parrish II New Brunswick, N.J. Transaction Publishers 2003 xxviii, 163 p. ill. : 24 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references (p. 139-155) and index Drug Industry standards United States Government Regulation history United States Health Policy history United States Legislation, Drug history United States Pharmaceutical Preparations standards United States Pharmaceutical policy United States Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Regulierung (DE-588)4201190-5 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittelmarkt (DE-588)4003131-7 s Regulierung (DE-588)4201190-5 s DE-604 http://www.loc.gov/catdir/toc/fy036/2002075086.html Table of contents GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010040905&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Parrish, Richard Henry Defining drugs how government became the arbiter of pharmaceutical fact Drug Industry standards United States Government Regulation history United States Health Policy history United States Legislation, Drug history United States Pharmaceutical Preparations standards United States Pharmaceutical policy United States Arzneimittelmarkt (DE-588)4003131-7 gnd Regulierung (DE-588)4201190-5 gnd |
subject_GND | (DE-588)4003131-7 (DE-588)4201190-5 (DE-588)4078704-7 |
title | Defining drugs how government became the arbiter of pharmaceutical fact |
title_auth | Defining drugs how government became the arbiter of pharmaceutical fact |
title_exact_search | Defining drugs how government became the arbiter of pharmaceutical fact |
title_full | Defining drugs how government became the arbiter of pharmaceutical fact Richard Henry Parrish II |
title_fullStr | Defining drugs how government became the arbiter of pharmaceutical fact Richard Henry Parrish II |
title_full_unstemmed | Defining drugs how government became the arbiter of pharmaceutical fact Richard Henry Parrish II |
title_short | Defining drugs |
title_sort | defining drugs how government became the arbiter of pharmaceutical fact |
title_sub | how government became the arbiter of pharmaceutical fact |
topic | Drug Industry standards United States Government Regulation history United States Health Policy history United States Legislation, Drug history United States Pharmaceutical Preparations standards United States Pharmaceutical policy United States Arzneimittelmarkt (DE-588)4003131-7 gnd Regulierung (DE-588)4201190-5 gnd |
topic_facet | Drug Industry standards United States Government Regulation history United States Health Policy history United States Legislation, Drug history United States Pharmaceutical Preparations standards United States Pharmaceutical policy United States Arzneimittelmarkt Regulierung USA |
url | http://www.loc.gov/catdir/toc/fy036/2002075086.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010040905&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT parrishrichardhenry definingdrugshowgovernmentbecamethearbiterofpharmaceuticalfact |